Changes in Capio's Nomination Committee

AP4 is now represented by Per Colleen, Head of Equites.

Steven Dyson, representing Apax Europe VI Fund Group, has decided to leave his assignment in Capio's Nomination Committee without Apax Europe VI Fund Group appointing a new representative.

In accordance with the instructions for the Nomination Committee, the Nomination Committee has asked Fjärde AP-fonden, being the sixth largest shareholder of Capio, to nominate a representative and Fjärde AP-fonden has nominated Per Colleen, who has been appointed new member of the Nomination Committee.

The other members in the committee is:

  • Anders Narvinger (the Chairman of the Board)
  • Robert Furuhjelm, Nordic Capital Fund VI
  • Bo Lundgren, Swedbank Robur fonder
  • Joakim Rubin, Zerez Capital
  • Per Hesselmark, R12 Kapital

_____________________________

Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services in four countries through its hospitals, specialist clinics and primary care units. Capio operates across three geographic segments: Nordic (54 percent of Group net sales 2015), France (38 percent of Group net sales 2015) and Germany (8 percent of Group net sales 2015).


Per Colleen

Per Colleen is Head of Equities at AP4, and has now been appointed as member of Capio's Nomination Committee.